Combined analysis of EPHX1, GSTP1, GSTM1 and GSTT1 gene polymorphisms in relation to chronic obstructive pulmonary disease risk and lung function impairment

Disease Markers

Volumn 30, Issue 5, 2011, Pages 253-263

  Lakhdar, Ramzi ^a   Denden, Sabri ^a   Knani, Jalel ^b   Leban, Nadia ^a   Daimi, Houria ^a   Hassine, Mohsen ^c   Lefranc, Gérard ^d   Chibani, Jemni Ben ^a   Khelil, Amel Haj ^a  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b CHU Tahar Sfar   (Tunisia)

^c FATTOUMA BOURGUIBA UNIVERSITY HOSPITAL   (Tunisia)

^d INSTITUTE OF HUMAN GENETICS   (France)

Author keywords

Chronic obstructive pulmonary disease; emphysema; genetic polymorphism; glutathione S transferase; microsomal epoxide hydrolase

Indexed keywords

ALANINE; ARGININE; EPOXIDE HYDROLASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; HISTIDINE; LEUCINE; MICROSOMAL EPOXIDE HYDROLASE 1; TYROSINE; UNCLASSIFIED DRUG; VALINE;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DNA POLYMORPHISM; EMPHYSEMA; FEMALE; FORCED EXPIRATORY VOLUME; GENE DELETION; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; LONGITUDINAL STUDY; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TUNISIA;

EID: 79960709307     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.3233/DMA-2011-0782     Document Type: Article

References (49)

1. B.R. Celli, W. Mac Nee and ATS/ERS, Task Force Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper, Eur Respir J 23 (2004), 932-946. (Pubitemid 38807371)
2. A. Lokke, P. Lange, H. Scharling, P. Fabricius and J. Vestbo, Developing COPD: a 25 year follow up study of the general population, Thorax 61 (2006), 935-939. (Pubitemid 44787161)
3. R. Bascom, Differential susceptibility to tobacco smoke: possible mechanisms, Pharmacogenetics 1 (1991), 102-106.
4. R. Ugenskiene, M. Sanak, R. Sakalauskas and A. Szczek-lik, Genetic polymorphisms in chronic obstructive pulmonary disease, Medicina (Kaunas) 41 (2005), 17-22.
5. N. Hizawa, Genetic backgrounds of asthma and COPD, Aller-gol Int 58 (2009), 315-322.
6. C.A. Smith and D.J. Harrison, Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema, Lancet 350 (1997), 630-633. (Pubitemid 27367797)
7. A.J. Sandford, T. Chagani, T.D. Weir, J.E. Connett, N.R. An-thonisen and P.D. Pare, Susceptibility genes for rapid decline of lung function in the lung health study, Am J Respir Crit Care Med 163 (2001), 469-473. (Pubitemid 32158530)
8. J.Y. Park, L. Chen, N. Wadhwa and M.S. Tockman, Polymorphisms for microsomal epoxide hydrolase and genetic susceptibility to COPD, Int J Mol Med 15 (2005), 443-448.
9. C.P. Hersh, D.L. De Meo, C. Lange, A.A. Litonjua, J.J. Reil-ly, D. Kwiatkowski, N. Laird, J.S. Sylvia, D. Sparrow, F.E. Speizer, S.T. Weiss and E.K. Silverman, Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations, Am J Respir Cell Mol Biol 33 (2005), 71-78. (Pubitemid 40961016)
10. J.J. Yim, G.Y. Park, C.T. Lee, Y.W. Kim, S.K. Han, YS. Shim and C.G. Yoo, Genetic susceptibility to chronic obstructive pulmonary disease in Koreans: combined analysis of polymorphic genotypes for microsomal epoxide hydrolase and glutathione S-transferase M1 and T1, Thorax 55 (2000), 121-125. (Pubitemid 30245951)
11. K. Takeyabu, E. Yamaguchi, I. Suzuk, M. Nishimura, N. Hizawa and Y. Kamakami, Gene polymorphism for microsomal epoxide hydrolase and susceptibility to emphysema in a Japanese population, Eur Respir J15 (2000), 891-894. (Pubitemid 30321846)
12. S.L. Cheng, C.J. Yu, C.J. Chen and P.C. Yang, Genetic polymorphism of epoxide hydrolase and glutathione S-transferase in COPD, Eur Respir J 23 (2004), 818-824.
13. J. Zidzik, E. Slaba, P. Joppa, Z. Kluchova, Z. Dorkova, P. Skyba, V. Habalova, J. Salagovic and R. Tkacova, Glutathione S-transferase and Microsomal Epoxide Hydrolase Gene Polymorphisms and Risk of Chronic Obstructive Pulmonary Disease in Slovak Population, Croat Med J 49 (2008), 182-191. (Pubitemid 351669458)
14. J. Lee, B.G. Nordestgaard and M. Dahl, EPHX1 polymorphisms, COPD and asthma in 47, 000 individuals and in meta-analysis, Eur Respir J (2010), doi: 10.1183/09031936. 00012110.
15. B. Ketterer, D.J. Meyer and A.G. Clark, Soluble glutathione transferase isoenzymes. In: Sies H, Ketterer B, eds., Glutathione conjugation, London: Academic Press (1988), 357-386.
16. J.O. Curtis, C. Hassett and V. Hosagrahara, Epoxide hydrolase - polymorphism and role in toxicologym Toxicol Lett 112 (2000) 365-370. (Pubitemid 30138145)
17. C. Hassett, L. Aicher, J.S. Sidhu and C.J. Omiecinski, Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants, Hum Mol Genet 3 (1994), 421-428. (Pubitemid 24083901)
18. A.S. Johansson, G. Stenberg, M. Widersten and B. Mannervik, Structure activity relationships and thermal stability of human glutathione transferase P1-1 governed by the H-site residue 105, J Mol Biol 278 (1998), 687-698. (Pubitemid 28224864)
19. D.J. Harrison, A.M. Cantlay, F. Rae, D. Lamb and C.A. Smith, Frequency of glutathione S transferase M1 deletion in smokers with emphysema and lung cancer, Hum Exp Toxicol 16 (1997), 356-360. (Pubitemid 27371243)
20. H. Baranova, J. Perriot, E. Albuisson, T. Ivaschenko, V.S. Baranov, B. Hemery, P. Mouraire, N. Riol and P. Malet, Peculiarities of the GSTM1 0/0 genotype in French heavy smokers with various types of chronic bronchitis, Hum Genet 99 (1997), 822-826. (Pubitemid 27243765)
21. T. Ishii, T. Matsuse, S. Teramoto, H. Matsui, M. Miyao, T. Hosoi, H Takahashi, Y. Fukuchi and Y. Ouchi, Glutathione S-transferase P1 (GSTP1) polymorphism in patients with chronic obstructive pulmonary disease, Thorax 54 (1999), 693-696. (Pubitemid 29341405)
22. D. Xiao, C. Wang, M.J. Du, B.S. Pang, H.Y Zhang, B. Xiao, J.Z. Liu, X.Z. Weng, L. Su and D.C. Christiani, Relationship between polymorphisms of genes encoding microsomal epoxide hydrolase and glutathione S-transferase P1 and chronic obstructive pulmonary disease, Chin Med J117 (2004), 661-667. (Pubitemid 38735820)
23. F Rodríguez, C. de la Roza, R. Jardi, M. Schaper, R. Vidal and M. Miravitlles, Glutathione S-Transferase P1 and Lung Function in Patients With a 1-Antitrypsin Deficiency and COPD, Chest 127 (2005), 1537-1543. (Pubitemid 46218777)
24. J. Smolonska, C. Wijmenga, D.S. Postma and H.M. Boezen, Meta-analyses on suspected chronic obstructive pulmonary disease genes: a summary of 20 years' research, Am J Respir Crit Care Med 180 (2009), 618-631.
25. F. Yan, C. Chen, J. Jing, W. Li, H. Shen and X. Wang, Association between polymorphism of glutathione S-transferase P1 and chronic obstructive pulmonary disease: a meta-analysis, Respir Med 104 (2010), 473-480.
26. P.J. Castaldi, M.H. Cho, M. Cohn, F. Langerman, S. Moran, N. Tarragona, H. Moukhachen, R. Venugopal, D. Hasimja, E. Kao, B. Wallace, C.P. Hersh, S. Bagade, L. Bertram, E.K. Silverman and T.A. Trikalinos, The COPD genetic association compendium: a comprehensive online database of COPD genetic associations, Hum Mol Genet 19 (2010), 526-534.
27. R. Lakhdar, S. Denden, J. Knani, N. Leban, H. Daimi, M. Hassine, G. Lefranc, J. Ben Chibani and A. Haj Khelil, Association between GST M1 and GSTT1 polymorphisms with COPD in Tunisian population, J Biochem Genet 48 (2010), 647-657.
28. R. Lakhdar, S. Denden, J. Knani, N. Leban, H. Daimi, M. Has-sine, G. Lefranc, J. Ben Chibani and A. Haj Khelil, Relationship between glutathione S-transferase P1 polymorphisms and chronic obstructive pulmonary disease in Tunisian population, Genet Mol Res 9 (2010), 897-907.
29. R. Lakhdar, S. Denden, J. Knani, N. Leban, H. Daimi, M. Hassine, G. Lefranc, J. Ben Chibani and A. Haj Khelil, Mi-crosomal epoxide hydrolase gene (EPHX1) polymorphisms and susceptibility to chronic obstructive pulmonary disease in Tunisian population, Genet Test Mol Biomarkers DOI: 10.1089/gtmb.2009.0168.
30. L.G. Dsavis, M.D. Dibner and J.F. Batte, Basic methods in molecular biology. Elsevier, New York (1986), 44-87.
31. M. Arand, R. Muhlbauer, J. Hengstler, E. Jäger, J. Fuchs, L. Winkler and F. Oesch, A multiplex polymerase chain reaction protocol for the simultaneous analysis of the glu-tathione S-transferase GSTM1 and GSTT1 polymorphisms, Anal Biochem 236 (1996), 184-186. (Pubitemid 26100747)
32. N.A. Molfino, Genetics of COPD, Chest 125 (2004), 1929-1940. (Pubitemid 38648430)
33. L. Joos, J.Q. He, M.B. Shepherdson, J.E. Connett, N.R. An-thonisen, P.D. Pare and A.J. Sandford, The role of matrix met-alloproteinase polymorphisms in the rate of decline in lung function, Hum Mol Genet 11 (2002), 5679-5676.
34. H.H. Nelson, J.K. Wiencke, D.C. Christiani, T.J. Cheng, Z.F. Zuo, B.S. Schwartz, B.K. Lee, M.R. Spitz, M. Wang, X. Xu et al., Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta, Carcino-genesis 16 (1995), 1243-1245.
35. C.L. Chen, Q. Liu and M.V. Relling, Simultaneous characterization of glutathione S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacks, Pharmacogenetics 6 (1996), 187-191. (Pubitemid 26151949)
36. E.K. Silverman, Progress in chronic obstructive pulmonary disease genetics, Proc Am Thorac Soc 3 (2006), 405-408. (Pubitemid 44033353)
37. R. Tkacova, J. Salagovic, M. Ceripkova, I. Tkac, J. Stubna and I. Kalina, Glutathione S-transferase M1 gene polymorphism is related to COPD in patients with non-small-cell lung cancer, Wien Klin Wochenschr 116 (2004), 131-134. (Pubitemid 38313540)
38. D.L. De Meo, C.P. Hersh, E.A. Hoffman, A.A. Litonjua, R. Lazarus, D. Sparrow, J.O. Benditt, G. Criner, B. Make, F.J. Martinez, P.D. Scanlon, F.C. Sciurba, J.P. Utz, J.J. Reilly and E.K. Silverman, Genetic Determinants of Emphysema Distribution in the National Emphysema Treatment Trial, Am J Respir Crit Care Med 176 (2007), 42-48. (Pubitemid 47048053)
39. A.A. Fryer, R. Hume and R.C. Strange, The development of glutathione S-transferase and glutathione peroxidase activities in human lung, Biochim Biophys Acta 883 (1986), 448-453. (Pubitemid 16001543)
40. J. Seidegard and G. Ekstrom, The role of human glutathione transferases and epoxide hydrolases in the metabolism of xenobiotics, Environ Health Perspect 105 (1997), 791-799. (Pubitemid 27372964)
41. G.M. Hunninghake, M.H. Cho, Y. Tesfaigzi, M.E. Soto-Quiros, L. Avila, J. Lasky-Su, C. Stidley, E. Melén, C. Söderhäll, J. Hallberg, I. Kull, J. Kere, M. Svartengren, G. Per-shagen, M. Wickman, C. Lange, D.L. Demeo, C.P. Hersh, B.J. Klanderman, B.A. Raby, D. Sparrow, S.D. Shapiro, E.K. Sil-verman, A.A. Litonjua, S.T. Weiss and J.C. Celedón, MMP12, lung function, and COPD in high-risk populations, N Engl J Med 361 (2009), 2599-2608.
42. E. Repapi, I. Sayers, L.V. Wain, P.R. Burton, T. Johnson, M. Obeidat, J.H. Zhao, A. Ramasamy, G. Zhai, V. Vitart, J.E. Huffman, W. Igl, E. Albrecht, P. Deloukas, J. Henderson, R. Granell, W.L. McArdle, A.R. Rudnicka, Wellcome Trust Case Control Consortium, I. Barroso, R.J. Loos, N.J. Wareham, L. Mustelin, T. Rantanen, I. Surakka, M. Imboden, H.E. Wichmann, I. Grkovic, S. Jankovic, L. Zgaga, A.L. Har-tikainen, L. Peltonen, U. Gyllensten, A. Johansson, G. Zaboli, H. Campbell, S.H. Wild, J.F. Wilson, S. Gläser, G. Homuth, H. Völzke, M. Mangino, N. Soranzo, T.D. Spector, O. Polasek, I. Rudan, A.F. Wright, M. Heliövaara, S. Ripatti, A. Pouta, A.T. Naluai, A.C. Olin, K. Torén, M.N. Cooper, A.L. James, L.J. Palmer, A.D. Hingorani, S.G. Wannamethee, P.H. Whin-cup, G.D. Smith, S. Ebrahim, T.M. McKeever, I.D. Pavord, A.K. Mac Leod, A.D. Morris, D.J. Porteous, C. Cooper, E. Dennison, S. Shaheen, S. Karrasch, E. Schnabel, H. Schulz, H. Grallert, N. Bouatia-Naji, J. Delplanque, P. Froguel, J.D. Blakey; NSHD Respiratory Study Team, J.R. Britton, R.W. Morris, J.W. Holloway, D.A. Lawlor, J. Hui, F. Nyberg, M.R. Jarvelin, C. Jackson, M. Kähönen, J. Kaprio, N.M. Probst-Hensch, B. Koch, C. Hayward, D.M. Evans, P. Elliott, D.P. Strachan, I.P. Hall and M.D. Tobin, Genome-wide association study identifies five loci associated with lung function, Nat Genet 42 (2010), 36-44.
43. M. Siedlinski, D.S. Postma, J.M. Boer, G. van der Steege, J.P. Schouten, H.A. Smit and H.M. Boezen, Level and course of FEV1 in relation to polymorphisms in NFE2L2 and KEAP1 in the general population. Respir Res 10 (2009), 73.
44. C.E Stewart, I.P. Hall, S.G. Parker, M.F. Moffat, A.J. Wardlaw, M.J. Connolly, C. Ruse and I. Sayers, PLAUR polymorphisms and lung function in UK smokers, BMC Med Genet 10 (2009), 112.
45. A. Kaparianos, E. Argyropoulou, G. Efremidis, C. Flordel-lis and K. Spiropoulos, Decline in FEV1 related to genetic polymorphisms (+138ins A/del A and Lys198Asn) of the endothelin-1 gene in COPD. A pilot study, Eur Rev Med Pharmacol Sci 14 (2010), 705-719.
46. A. Vibhuti, E. Arif, D. Deepak, B. Singh and M.A. Qadar Pasha, Genetic polymorphisms of GSTP1 and m EPHX correlate with oxidative stress markers and lung function in COPD, Biochem Biophys Res Commun 359 (2007), 136-142. (Pubitemid 46836679)
47. M. Siedlinski, D.S. Postma, H.A. Smit and H.M. Boezen, No effects of EPHX1 polymorphisms on the level or change of FEV1 in the general population, Eur Respir J 33 (2009), 446-449.
48. J.Q. He, J. Ruan, J.E. Connett, N.R. Anthonisen, P.D. Paré and A.J. Sandford, Antioxidant Gene Polymorphisms and Susceptibility to a Rapid Decline in Lung Function in Smokers, Am J Respir Crit Care Med 166 (2002), 323-328. (Pubitemid 34864420)
49. M. Imboden, S.H. Downs, O. Senn, G. Matyas, O. Brändli, E.W. Russi, C. Schindler, U. Ackermann-Liebrich, W. Berg-er, N.M. Probst-Hensch and SAPALDIA Team, Glutathione S-transferase genotypes modify lung function decline in the general population: SAPALDIA cohort study, Respir Res 8 (2007), 2.